Debt-to-equity of TherapeuticsMD, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
TherapeuticsMD, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • TherapeuticsMD, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 42%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

TherapeuticsMD, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 42% 30 Sep 2025
Q4 2023 72% +452% 31 Dec 2023
Q3 2023 101% +390% 30 Sep 2023
Q2 2023 574% +881% 30 Jun 2023
Q1 2023 -6100% -5787% -1853% 31 Mar 2023
Q4 2022 -380% +115% +23% 31 Dec 2022
Q3 2022 -289% +162% +36% 30 Sep 2022
Q2 2022 -307% +64% +17% 30 Jun 2022
Q1 2022 -312% +22% +6.5% 31 Mar 2022
Q4 2021 -496% -176% -55% 31 Dec 2021
Q3 2021 -451% +22% +4.7% 30 Sep 2021
Q2 2021 -371% +383% +51% 30 Jun 2021
Q1 2021 -334% +1864% +85% 31 Mar 2021
Q4 2020 -320% -1883% -120% 31 Dec 2020
Q3 2020 -473% -986% -192% 30 Sep 2020
Q2 2020 -754% -946% -493% 30 Jun 2020
Q1 2020 -2198% -2315% -1980% 31 Mar 2020
Q4 2019 1564% 31 Dec 2019
Q3 2019 514% 30 Sep 2019
Q2 2019 192% 30 Jun 2019
Q1 2019 117% 31 Mar 2019
Q4 2015 16% 31 Dec 2015
Q3 2015 17% 30 Sep 2015
Q2 2014 14% -19% -59% 30 Jun 2014
Q1 2014 12% -62% -83% 31 Mar 2014
Q4 2013 12% +272% 31 Dec 2013
Q3 2013 16% +228% 30 Sep 2013
Q2 2013 33% +259% 30 Jun 2013
Q1 2013 75% +225% 31 Mar 2013
Q4 2012 -261% 31 Dec 2012
Q3 2012 -212% 30 Sep 2012
Q2 2012 -226% 30 Jun 2012
Q1 2012 -150% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.